• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Show Search
Home
EN / FR
  • LinkedIn
  • Twitter
Celyad Oncology

Celyad Oncology

  • About Us
    • Overview
    • Management Team
    • Board Of Directors
    • Partners
  • Science
    • Overview
    • Approach
    • Technology
      • TIM
      • shRNA
      • shARC Platform
    • Manufacturing
    • Scientific Publications
  • Pipeline
  • Newsroom
    • Press Releases
    • Events
    • Media Center
  • Investors
    • Overview
    • Analyst Coverage
    • Corporate Governance
    • Regulated Information
    • Shareholders Information
    • Shareholders Meeting
  • Careers
  • Contact Us

First Half 2022 Financial Results

May 25, 2022 By Celyad Oncology

H.C. Wainwright Global Investment Conference

May 17, 2022 By Celyad Oncology

On-demand starting May 24, 7 a.m ET / 1 p.m. CET

Full Year 2021 Financial Results and Recent Business Highlights

March 17, 2022 By Celyad Oncology

Call at 8 a.m. ET / 1 p.m. CET

11th Annual SVB Leerink Global Healthcare Conference

January 31, 2022 By Celyad Oncology

Presentation Time: 8:00 a.m. ET / 2 p.m. CET

H.C. Wainwright BioConnect 2022 Conference

December 22, 2021 By Celyad Oncology

On-demand starting January 10, 7 a.m. ET / 1 p.m. CET

ASCO GI 2022

December 16, 2021 By Celyad Oncology

January 20-22, 2022

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 14
  • Go to Next Page »

Footer

Celyad Oncology Logo
  • About
  • Science
  • Pipeline
  • Newsroom
  • Investors
  • Contact Us
  • LinkedIn
  • Twitter

Copyright © 2020 All Rights Reserved.
Cookie Policy | Privacy Policy | Terms of Use